Lia Visintin

Ms. Lia Visintin

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2021 in Molecules
Verified
Journal Article
Open access
PDF file
EAEleonora Amante
Eleonora Amante
EAEugenio Alladio
Eugenio Alladio
RRRebecca Rizzo
Rebecca Rizzo
DCDaniele Di Corcia
Daniele Di Corcia
PNPierre Negri
Pierre Negri
ASAlberto Salomone
Alberto Salomone
The misuse of fentanyl, and novel synthetic opioids (NSO) in general, has become a public health emergency, especially in the United States. The detection of NSO is often challenged by the limited diagnostic time frame allowed by urine sampling and the wide range of chemically modified analogues, continuously introduced to the recreational drug market. In this study, an untargeted metabolomics approach was developed to obtain a comprehensive “fingerprint” of any anomalous and specific metabolic pattern potentially related to fentanyl exposure. In recent years, in vitro models of drug metabolism have emerged as important tools to overcome the limited access to positive urine samples and uncertainties related to the substances actually taken, the possible combined drug intake, and the ingested dose. In this study, an in vivo experiment was designed by incubating HepG2 cell lines with either fentanyl or common drugs of abuse, creating a cohort of 96 samples. These samples, together with 81 urine samples including negative controls and positive samples obtained from recent users of either fentanyl or “traditional” drugs, were subjected to untargeted analysis using both UHPLC reverse phase and HILIC chromatography combined with QTOF mass spectrometry. Data independent acquisition was performed by SWATH in order to obtain a comprehensive profile of the urinary metabolome. After extensive processing, the resulting datasets were initially subjected to unsupervised exploration by principal component analysis (PCA), yielding clear separation of the fentanyl positive samples with respect to both controls and samples positive to other drugs. The urine datasets were then systematically investigated by supervised classification models based on soft independent modeling by class analogy (SIMCA) algorithms, with the end goal of identifying fentanyl users. A final single-class SIMCA model based on an RP dataset and five PCs yielded 96% sensitivity and 74% specificity. The distinguishable metabolic patterns produced by fentanyl in comparison to other opioids opens up new perspectives in the interpretation of the biological activity of fentanyl.

24 January 2025 in Journal of Exposure Science & Environmental Epidemiology
Verified
Journal Article
Open access
PDF file
LVLia Visintin
Lia Visintin
ELEn-Hsuan Lu
En-Hsuan Lu
HLHsing-Chieh Lin
Hsing-Chieh Lin
YBYasmine Bader
Yasmine Bader
TNTruong Nhat Nguyen
Truong Nhat Nguyen
MBMarthe De Boevre
Marthe De Boevre
Background: Tenuazonic acid (TeA), a mycotoxin produced by Alternaria alternata, contaminates various food commodities and is known to cause acute and chronic health effects. However, the lack of human toxicokinetic (TK) data and the reliance on external exposure estimates have stalled a comprehensive risk assessment for TeA. Objective: To bridge this gap, a human TK trial and population-based TK (PopTK) modeling were applied to determine human TK parameters of TeA, and the results were applied for risk screening using population biomonitoring data and threshold of toxicological concern (TTC)-based approaches. Methods: Ten healthy volunteers participated in the TK trial during which the volunteers ingested a bolus dose of TeA at the (external) TTC (1500 ng/kg bw). Blood, urine, and fecal samples were collected over 48 h and analyzed using UPLC-MS/MS. Concentration-time profiles were fit with a multi-compartmental PopTK model using a hierarchical Bayesian population structure. Utilizing a probabilistic framework, fitted TK parameters were used to derive internal TTC (iTTC) values for comparison to blood and urine biomonitoring data. Risk screening with data from five diverse biomonitoring cohorts was performed using Hazard Quotient (HQ) and probabilistic individual margin of exposure (IMOE) approaches. Results: TeA was estimated to have a population median half-life of 1.9 [90% CI: 1.4–2.7] hours and volume of distribution of 4.4 [3.1–6.1] L/kg, with inter-individual variability geometric standard deviations of 2.4- and 1.7-fold, respectively. Probabilistic lower confidence bound iTTCs were derived of 0.5 nmol/L in blood and 2.53 nmol/kg-d urinary excretion. Risk screening HQs were mostly >1 for the three blood biomonitoring cohorts and < 1 for the two urinary biomonitoring cohorts; results from probabilistic IMOE calculations were qualitatively consistent. Significance: A comprehensive human TK study was performed for TeA for the first time, demonstrating the importance of integrating TK and population variability for a more comprehensive risk evaluation, particularly for interpreting biomonitoring data. The results for TeA point to the critical need for toxicity data to move beyond TTC-based risk screening. Impact: A critical gap in food safety research was addressed studying the toxicokinetics of tenuazonic acid (TeA) in humans and using these data to derive an internal threshold of toxicological concern (iTTC) for comparison to human biomonitoring data. The innovative approach—combining a human intervention trial with population-based toxicokinetic modeling—accounts for inter-individual variability and provides a more comprehensive understanding of population exposure to TeA. The resulting probabilistic iTTC and risk screening methodologies offer improved tools for interpretation of biomonitoring data. These findings have significant implications for food safety regulations and public health protection, potentially influencing future mycotoxin risk assessment strategies.

10 November 2023 in Food and Chemical Toxicology
Verified
Journal Article
Open access
LVLia Visintin
Lia Visintin
MNMaría García Nicolás
María García Nicolás
PVPablo Vangeenderhuysen
Pablo Vangeenderhuysen
TGTess Goessens
Tess Goessens
EAEugenio Alladio
Eugenio Alladio
Marthe De BoevreMarthe De Boevre
Marthe De Boevre
Mycotoxins are secondary metabolites produced by fungi such as Aspergillus, Alternaria, and Penicillium , affecting nearly 80% of global food crops. Tenuazonic acid (TeA) is the major mycotoxin produced by Alternaria alternata, a prevalent pathogen affecting plants, fruits, and vegetables. TeA is notably prevalent in European diets, however, TeA biomarkers of exposure and metabolites remain unknown. This research aims to bridge this knowledge-gap by gaining insights about human TeA exposure and metabolization. Nine subjects were divided into two groups. The first group received a single bolus of TeA at the Threshold of Toxicological Concern (TTC) to investigate the presence of TeA urinary biomarkers, while the second group served as a control. Sixty-nine urinary samples were prepared and analyzed using UPLC-Xevo TQ-XS for TeA quantification and UPLC-Orbitrap Exploris for polar metabolome acquisition. TeA was rapidly excreted during the first 13 h and the fraction extracted was 0.39 ± 0.22. The polar metabolome compounds effectively discriminating the two groups were filtered using Orthogonal Partial Least Squares-Discriminant Analysis and subsequently annotated (n = 122) at confidence level 4. Finally, the urinary metabolome was compared to in silico predicted TeA metabolites. Nine metabolites, including oxidized, N-alkylated, desaturated, glucuronidated, and sulfonated forms of TeA were detected.

Carla MartinsCarla Martins
Carla Martins
Ricardo AssunçãoRicardo Assunção
Ricardo Assunção
ACAna Costa
Ana Costa
DSDébora Serrano
Débora Serrano
LVLia Visintin
Lia Visintin
CNCarla Nunes
Carla Nunes
Early-life exposure occurs during gestation through transfer to the fetus and later, during lactation. Recent monitoring data revealed that the Portuguese population is exposed to mycotoxins, including young children. This study aimed to develop a pilot study to assess the early-life exposure to mycotoxins through a mother–child cohort, and to identify the associated challenges. Participants were recruited during pregnancy (1st trimester) and followed-up in three moments of observation: 2nd trimester of pregnancy (mother), and 1st and 6th month of the child’s life (mother and child), with the collection of biological samples and sociodemographic and food consumption data. The earlyMYCO pilot study enrolled 19 mother–child pairs. The analysis of biological samples from participants revealed the presence of 4 out of 15 and 5 out of 18 mycotoxins’ biomarkers of exposure in urine and breast milk samples, respectively. The main aspects identified as contributors for the successful development of the cohort were the multidisciplinary and dedicated team members in healthcare units, reduced burden of participation, and the availability of healthcare units for the implementation of the fieldwork. Challenges faced, lessons learned, and suggestions were discussed as a contribution for the development of further studies in this area.

28 June 2024 in Toxins
Verified
Journal Article
Open access
PDF file
LVLia Visintin
Lia Visintin
MNMaría García Nicolás
María García Nicolás
Sarah De SaegerSarah De Saeger
Sarah De Saeger
Marthe De BoevreMarthe De Boevre
Marthe De Boevre
Mycotoxins, natural toxins produced by fungi, contaminate nearly 80% of global food crops. Alternaria mycotoxins, including alternariol (AOH), alternariol monomethylether (AME), and tenuazonic acid (TeA), present a health concern due to their prevalence in various plants and fruits. Exposure to these toxins exceeds the threshold of toxicological concern in some European populations, especially infants and toddlers. Despite this, regulatory standards for Alternaria toxins remain absent. The lack of toxicokinetic parameters, reference levels, and sensitive detection methods complicates risk assessment and highlights the necessity for advanced biomonitoring (HBM) techniques. This study addresses these challenges by developing and validating ultra-high performance liquid chromatography method coupled with tandem mass spectrometry to quantify AOH, AME, TeA, and their conjugates in multiple biological matrices. The validated method demonstrates robust linearity, precision, recovery (94–111%), and sensitivity across urine (LOD < 0.053 ng/mL), capillary blood (LOD < 0.029 ng/mL), and feces (LOD < 0.424 ng/g), with significantly lower LOD for TeA compared to existing methodologies. The application of minimally invasive microsampling techniques for the blood collection enhances the potential for large-scale HBM studies. These advancements represent a step toward comprehensive HBM and exposure risk assessments for Alternaria toxins, facilitating the generation of data for regulatory authorities.

7 November 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
LVLia Visintin
Lia Visintin
EAEugenio Alladio
Eugenio Alladio
MNMaría García Nicolás
María García Nicolás
Sarah De SaegerSarah De Saeger
Sarah De Saeger
ELEn-Hsuan Lu
En-Hsuan Lu
Marthe De BoevreMarthe De Boevre
Marthe De Boevre
Mycotoxin exposure contributes to adverse human health outcomes, however, data regarding validated human biomarkers of exposure are lacking. This study presents an integrated framework for the biomarker discovery and toxicokinetic characterization of mycotoxin in humans. The aim of the study is to identify new biomarkers, determine their toxicokinetic (TK) properties, and build an integrated data analysis workflow using machine learning (ML), whilst focusing on non- and minimally-invasive sampling strategies. Following sample collection and chemical analysis, obtained datasets are used for the computation of ML models. Probability-based techniques are employed to calculate specific boundaries in the multidimensional space and, in parallel, ML classification methodologies are evaluated to scrutinize controls from intervened volunteers. Furthermore, multivariate regression models are computed to study the correlation of potential biomarkers with mycotoxin dosages. Once biomarkers have been identified, data are fit using Bayesian methods to a population-TK model to estimate key parameters related to absorption, distribution, metabolism, and excretion. This standardized framework allows the scientific community to identify and validate new mycotoxin biomarkers and related ADME-properties in both a precise and accurate manner. Although we developed the proposed trial for various different mycotoxins, due to ethical considerations, focus was set towards IARC group III-classified mycotoxins.